Find Academic Supervisors

• Physiology
• Sports Science
• Molecular Biology
• +3 more

Tommy Lundberg is a Senior Lecturer and Docent in Physiology at Karolinska Institutet. He works at the Department of Laboratory Medicine, Division of Clinical Physiology. His email address is tommy.lundberg@ki.se, and his postal address is H5 Laboratoriomedicin, H5 Klinisk Fysiologi Gustafsson, 141 52 Huddinge. Lundberg is affiliated with the university library and has held positions since 2022. Research Interests: Lundberg's research focuses on skeletal muscle mass and function adaptation, particularly in athletic performance, disease contexts, aging, and transgender individuals undergoing hormone therapy. He investigates molecular, metabolic, morphological, and functional responses to resistance and aerobic exercises. His work also explores biological maturity selection biases in youth sports, bio-banding applications in soccer and ice hockey, and the impact of anti-inflammatory drugs on muscle hypertrophy. Article Trends: Lundberg's recent publications (2025–2024) cover topics like sex differences in disc golf, muscle atrophy in space exposome, longitudinal hormone therapy effects in transgender individuals, and bio-banding in youth sports. Earlier works delve into molecular pathways in muscle hypertrophy, concurrent training effects, mitochondrial function, and imaging techniques (CT/MRI) for muscle assessment. Scientific Recognition: Most prominent young researcher in Sport Science, Swedish Central Association for Sport Promotion (SCIF), 2017 Teaching and Editorial Roles: Lundberg teaches human physiology and sports science in nursing, physiotherapy, and biomedical analytics programs. He leads a contract education course in advanced exercise physiology and contributes to a PhD course on scientific writing. He is an Associate Editor for Frontiers in Physiology - Exercise Physiology (2022) and a member of the editorial board for Translational Exercise Biomedicine (2024). Collaborations and Expertise: He collaborates with the Swedish Football Association and Swedish Ice Hockey Association on bio-banding studies. Lundberg served as an invited speaker at the ACSM Annual Meeting (2024) on transgender athletes and as an expert panelist for World Rugby's transgender workshop (2020). His supervision includes Andrea Tryfonos (2021) and thesis evaluations at Mid Sweden University and Linköping University.

Rodrigo Fernandez GonzaloView profile

Associate Professor

• Physiology
• Skeletal Muscle Physiology
• Space Physiology
• +6 more

Rodrigo Fernandez Gonzalo is a Docent (Associate Professor) in Physiology and Principal Researcher at the Division of Clinical Physiology, Department of Laboratory Medicine, Karolinska Institutet. He leads the Space and Environmental Physiology research group focusing on skeletal muscle adaptation under various conditions including microgravity, aging, disease, and exercise. His research interests span skeletal muscle physiology, space physiology, and environmental physiology, with particular expertise in how skeletal muscle interacts with other physiological systems. His work employs diverse methodologies including human clinical studies, animal models, and cellular models to investigate functional, metabolic, morphological, molecular, and neural adaptations. Analysis of his recent publications reveals a strong focus on space physiology applications, particularly how microgravity affects skeletal muscle and immune systems, along with translational applications for clinical populations like those with cerebral palsy. His research integrates molecular analysis, imaging techniques, and physical performance outcomes to develop countermeasures for spaceflight effects. 4.5 MSEK funding from the Swedish National Space Agency (2020) Member of European Space Agency's Life Science Working Group (2022-2026) Member of Space Researchers Sweden (2021-) Dr. Fernandez Gonzalo serves as course responsible for Anatomy and Physiology in the nursing program (since 2018) and Advanced Human Physiology Research in the Master's programme in Translational Physiology and Pharmacology (since 2023). He also teaches Human Spaceflight at KTH and participates in the Erasmus Mundus Joint Master in Physiology and Medicine of Humans in Space and Extreme Environments. His laboratory utilizes facilities at Karolinska University Hospital and ANA Futura for human, animal, and cellular studies investigating space exposome effects.

Trung Nghia VuView profile

Researcher

• Bioinformatics
• Computational Biology
• Cancer Genomics
• +5 more

Trung Nghia Vu is a Principal Researcher at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet in Stockholm, Sweden. His research group focuses on developing and applying statistical and bioinformatics methods for molecular biology and medicine, with particular emphasis on cancer genomics and pharmacogenomics. Dr. Vu received his PhD from the Department of Mathematics and Computer Science at the University of Antwerp, Belgium (2009-2014), following an MSc in Computer Engineering from Korea Aerospace University (2006-2008) and a BSc in Technology from Vietnam National University in Hanoi (2000-2004). His research focuses on developing statistical and bioinformatics methodologies for analyzing high-throughput omics data, with specific interests in single-cell sequencing analysis, characterization of cancer omics, and pharmacogenomics. His group has developed 20 statistical and bioinformatics tools available through Biostat Wiki Primary research areas include gene/isoform quantification, detection of abnormal RNAs, single-cell RNA-seq analysis, and drug response prediction Current projects focus on breast cancer and Acute Myeloid Leukemia (AML) Analysis of Dr. Vu's recent publications reveals a strong focus on cancer genomics, particularly in AML and breast cancer. His work bridges computational biology with clinical applications, developing methods for spatial transcriptomics, drug synergy prediction, and circular RNA analysis. The research demonstrates a clear trajectory toward precision medicine applications, with increasing emphasis on personalized drug response prediction and pathway activation modeling. Dr. Vu actively supervises multiple students and researchers, including both completed PhD students (Quang Thinh Trac, Lu Pan, Wenjiang Deng) and ongoing supervisees (Gulser Caliskan, Meghana Alugunoolla, Yuying Li, Aron Arzoomand). His research is supported by significant grants from the Swedish Research Council, CancerFonden, and Karolinska Institutet. He leads the Computational Medicine and Bioinformatics research group at Karolinska Institutet, which collaborates with international clinical and systems-biology researchers. The group maintains active development of bioinformatics tools and maintains the Biostat Wiki platform for academic use. Dr. Vu also contributes to teaching through master's and doctoral courses in biostatistics and R programming at Karolinska Institutet.

Tanel PungaView profile

Senior Lecturer

• Virology
• Adenovirus
• Epigenetics
• +5 more

Tanel Punga is a Senior Lecturer at Uppsala University's Department of Medical Biochemistry and Microbiology, Faculty of Medicine. He serves as Director of Studies for the Doctoral Level and is affiliated with the Infections and Immunity research group. His work spans virology, immunology, and molecular biology with a focus on human adenovirus, myasthenia gravis, and epigenetic regulation. Dr. Punga's research interests encompass several interconnected areas of biomedical science: Virology : Particularly human adenovirus biology, including viral RNA metabolism, capsid protein functions, and host-virus interactions Neuromuscular Disorders : Focusing on myasthenia gravis pathogenesis, biomarker discovery, and microRNA regulation Epigenetics : Investigating DNA methylation patterns in viral infections and their impact on tumor suppressor genes RNA Biology : Studying RNA-binding proteins, microRNA functions, and non-coding RNA regulation in disease contexts Analysis of Dr. Punga's recent publications (2020-2025) reveals a strong focus on two primary research trajectories: adenovirus molecular biology and myasthenia gravis biomarker discovery. His adenovirus work investigates viral RNA metabolism, capsid protein functions, and host responses to infection. Simultaneously, his research on myasthenia gravis has identified multiple circulating microRNAs as potential diagnostic and prognostic biomarkers, with particular emphasis on miR-150-5p and other circulating microRNAs. His work increasingly integrates omics approaches to understand complex host-pathogen interactions and autoimmune mechanisms. Dr. Punga has contributed to numerous collaborative research projects, particularly in the areas of viral pathogenesis and autoimmune disorders. His work has been instrumental in establishing connections between viral infections and epigenetic modifications, as well as identifying novel biomarkers for neuromuscular disorders.

• Hepatocellular Carcinoma
• Liver Cirrhosis
• Non-alcoholic Fatty Liver Disease
• +4 more

Per Stål is an Adjunct Professor at Karolinska Institutet's Department of Medicine, Huddinge, and a Consultant at Karolinska University Hospital. His clinical expertise focuses on chronic liver diseases, particularly hepatocellular carcinoma (HCC) and cirrhosis. He leads the 'Rare metabolic liver diseases, coagulation and hepatocellular carcinoma' research group and teaches the SVK course in Liver and Pancreatic diseases for medical students. Research Focus Stål's research centers on improving early HCC detection in cirrhotic patients through biomarker validation (blood proteins, micro-RNA) and exploring immunotherapy approaches for advanced HCC. His work spans translational studies on neoantigens, T-cell therapies, and metabolic drivers of liver cancer. Key areas include: Biomarker discovery for hepatocellular carcinoma Non-alcoholic fatty liver disease (NAFLD) progression and outcomes Iron metabolism disorders in liver disease Immunotherapy mechanisms in liver cancer Publication Trends His recent articles (2023-2025) demonstrate strong emphasis on: Molecular diagnostics (DNA methylation, miRNA, proteomics) Clinical outcomes in NAFLD/MASLD cohorts Novel immunotherapies and T-cell targeting Epidemiology of viral hepatitis-related HCC with consistent focus on translating basic findings to clinical applications. Supervision Current and former PhD students include: Sanna Norén (Hemostasis in cirrhosis/HCC) Hannes Hegmar (research area unspecified) Research Group Co-leads the 'Stål and Wahlin research group' investigating rare metabolic liver diseases, coagulation disorders, and hepatocellular carcinoma pathogenesis through clinical and translational approaches.

Xiao-Feng SunView profile

Professor

• Molecular Oncology
• Colorectal Cancer Research
• MicroRNA Regulation
• +3 more

Xiao-Feng Sun serves as Professor at Linköping University, holding dual appointments in the Department of Biomedical and Clinical Sciences (BKV) and Department of Surgery, Orthopaedics and Oncology (KOO). His research is centered within the Wallenberg Centre for Molecular Medicine (WCMM), a Knut and Alice Wallenberg Foundation initiative advancing molecular medicine through university-healthcare collaboration. His research program investigates molecular drivers of colorectal cancer progression, with emphasis on: MicroRNA-mediated regulation (miR-122, miR-134) of oncogenes like AEG-1 Developmental pathway hijacking (Wnt/β-catenin, TBX3) in metastasis Therapeutic targeting of KRAS/PIK3CA signaling networks Translational validation from murine models to clinical data analysis Recent publications (2024-2025) reveal a cohesive trajectory toward clinical translation, particularly in microRNA-based therapeutics and metastasis intervention. His work bridges basic molecular mechanisms with diagnostic innovation, as evidenced by contributions to emerging colorectal cancer detection methodologies. Professor Sun actively contributes to LiU's cancer research ecosystem, which has secured substantial Swedish Cancer Foundation funding (SEK 24-34 million 2021-2025) for molecular mechanism studies and survival-improvement initiatives. His laboratory leverages WCMM's infrastructure for high-throughput molecular analysis and preclinical validation.

• Bioinformatics
• Systems Biology
• Computational Biology
• +7 more

Zelmina Lubovac-Pilav is a Senior Lecturer in Bioinformatics at the School of Bioscience, University of Skövde. She coordinates advanced and foundational courses in bioscience and serves as Programme Coordinator for Master's-level programs. Her research focuses on bioinformatics , systems biology , and disease module analysis , particularly in pancreatic cancer , multiple sclerosis , and breast cancer . Her work involves multi-omics data integration (genomics, proteomics, transcriptomics) and biomarker discovery , supported by projects like BIO-AID (AI-driven biomedical analytics) and DMDPipe (disease-causing protein modules in asthma). She develops computational tools such as MODalyseR and TFTenricher for disease module inference and transcription factor analysis. The 15 most recent articles highlight trends in latent space modeling , network biology , and clinical data analysis , with applications in pancreatic cancer early detection , multiple sclerosis biomarkers , and miRNA functional analysis . These studies emphasize algorithm development , data normalization , and community-driven network predictions . Contact: zelmina.lubovac@his.se

• Infectious Medicine
• Proteomics
• Sepsis
• +4 more

Erik Malmström is a Researcher at the Department of Infection Medicine within Lund University . He specializes in Proteomics , Inflammation , and Sepsis , with a focus on translational sepsis research and therapeutic interventions . Research Interests : Proteome dynamics in infectious diseases Multi-omics integration for digital twin modeling in sepsis Host-pathogen interactions at molecular levels Anti-inflammatory therapeutic strategies Research Output Trends : His work spans 2013–2025 and covers topics like Gram-negative sepsis , Covid-19 proteome profiling , and non-coding RNA regulation in monocytes. Techniques include mass spectrometry , pharmacoproteomics , and murine models . Projects : Active : Integration of mass spectrometry and AI for sepsis subphenotyping (2024–) Completed : Covid-19 proteome profiling with DNase therapy (2020–2021)

Edoardo SozziView profile

Research Fellow

• Neuroscience
• Neurobiology
• Stem Cell Research
• +6 more

Edoardo Sozzi is a Visiting Research Fellow and PhD student at Lund University's Faculty of Medicine, specializing in the Developmental and Regenerative Neurobiology group under Prof. Malin Parmar. He earned a BSc in Biotechnology (2018) and a dual MSc in Neuroscience (2020) from the University of Pisa and Scuola Normale Superiore, Italy. His research focuses on the development, functionality, and diversity of human dopaminergic neurons using 3D cell culture systems like brain organoids and xenograft models, with heavy reliance on single-cell RNA sequencing. His work intersects neuroscience, developmental biology, and regenerative medicine, targeting neurodegenerative disorders such as Parkinson's disease. Key publication trends include innovations in organoid technology , single-cell transcriptomics , and WNT signaling modulation . He has contributed to 11 scientific outputs , including a 2025 doctoral thesis, peer-reviewed articles in Nature Methods and Development , and a 2023 Horizon Europe grant (OpenMIND project) for opto-electronic neural modeling in neurodegenerative diseases. Sozzi actively participates in academic events, organizing conferences like Neuroscience Day 2024 and UniStem Day 2024 , and serves as a presenter in multidisciplinary initiatives (MultiPark). His work aligns with UN Sustainable Development Goals for Medical and Health Sciences and Neurosciences .

Per HydbringView profile

Researcher

• MicroRNAs in Cancer
• Lung Cancer
• Targeted Therapy Resistance
• +7 more

Per Hydbring is a Senior Research Specialist and Lecturer at the Department of Oncology-Pathology, Karolinska Institutet, where he leads his research team focused on coding and non-coding RNAs in cancer. His work intersects with Simon Ekman's Precision Cancer Medicine in Lung Cancer group, emphasizing targeted therapy resistance and RNA-based drug delivery. Academic Affiliation: Department of Oncology-Pathology, Karolinska Institutet Research Focus: MicroRNA mechanisms in therapy-resistant lung and breast cancers, cell cycle regulation via CDKs/cyclins, and systemic RNA delivery using lipid nanoparticles His research employs systematic genomic screens to identify RNA regulators of tumor refractoriness to tyrosine kinase inhibitors (TKIs) like osimertinib, with applications in patient outcome prediction and drug development. Collaborations include teams led by Dr. Simon Ekman and Dr. C. Norberg, supported by the Swedish Research Council and Stockholm Cancer Society. Dr. Hydbring obtained his Docent degree at Karolinska Institutet in 2023.

• Artificial Intelligence
• Sensor Technologies
• Drug Delivery Systems
• +4 more

Professor Amit Kumar-Mishra is affiliated with Halmstad University's Department of Artificial Intelligence and Sensor Technologies. His research spans interdisciplinary areas including AI-driven solutions for precision agriculture, drug delivery systems, cancer biology, and molecular imaging. He has authored over 30 publications in 2024-2025 alone, focusing on topics like pH-responsive nanocarriers for cancer therapy, circular RNA roles in cytokine signaling, and weed management strategies in mustard crops. Notable research contributions include development of deep neural network architectures for sensor technologies, investigation of salt stress adaptations in eggplant, and exploration of proteases for cancer diagnostics. His work integrates machine learning with agricultural challenges, such as real-time weed detection systems and hydroponics automation. Recent studies also explore novel biomarkers for ovarian cancer detection using circulating DNA analysis. Publications demonstrate a strong focus on translational research with applications in both clinical oncology and agricultural productivity. His research bridges computational methods with biological systems, emphasizing cross-disciplinary innovation in healthcare and food security domains.

• Odontology
• Oral Medicine
• Oral Diagnostics
• +4 more

Robert Heymann serves as an Adjunct Lecturer at Karolinska Institutet's Department of Dental Medicine, specifically within the Division of Oral Diagnostics and Surgery since 2021, with his appointment extending through 2028. His work bridges clinical dental practice and translational research in oral health sciences. His academic foundation includes: Doctor of Philosophy (2002) from the Department of Cell and Molecular Biology, Karolinska Institutet University Degree in Dental Surgery (1994) from Karolinska Institutet Heymann's research spans multiple domains of Odontology, with concentrated expertise in Oral Immunology, Oral Pathology, and Oral Diagnostics. His investigations explore the immunopathological mechanisms of oral mucosal diseases, particularly chronic graft-versus-host disease, while also examining cell adhesion molecules in tooth development and periodontal tissues. Recent work extends into oral oncology microbiome profiling and dental education innovation. Analysis of his 2001-2023 publications reveals evolving research trajectories: early work (2001-2002) established foundational knowledge in odontogenesis and cell adhesion, while contemporary research (2016-2023) demonstrates clinical translation through immunohistopathological studies of mucosal diseases and microbiological investigations in cancer patients. His 2016 dental education publication highlights cross-disciplinary application of simulation technology. Heymann actively contributes to dental education through web-based patient simulation programs for oral surgery training, as documented in the Journal of Dental Education. His research collaborations span multiple departments within Karolinska Institutet and international institutions, evidenced by co-authorship patterns. Based at Alfred Nobels Allé 8 in Huddinge, he operates within the Division of Oral Diagnostics and Surgery, maintaining a research-teaching nexus that addresses both fundamental biological mechanisms and clinical applications in dental medicine.

Malin EngfeldtView profile

Associate Professor

• Occupational Health
• Environmental Medicine
• Dermatology
• +3 more

Malin Engfeldt serves as an Associate Professor at Lund University within the Division of Occupational and Environmental Medicine. As an occupational hygienist and active researcher since 2019, she specializes in characterizing airborne workplace exposures while maintaining expertise in work-related skin diseases developed through her 2007 doctoral thesis in experimental dermatology on isocyanate contact allergy. Her research spans occupational toxicology and dermatology with emphases on hexavalent chromium exposure pathways, isocyanate sensitization mechanisms, and formaldehyde/Methylisothiazolinone allergy triggers. She employs biomonitoring, molecular toxicology, and epidemiological methods to investigate exposure-disease relationships, contributing significantly to UN Sustainable Development Goals through occupational health advancements. Recent publications (2024-2025) reveal a concentrated focus on hexavalent chromium biomonitoring through the SafeChrom project, demonstrating genotoxic effects and epigenetic alterations in exposed workers. Her work also bridges occupational exposures with broader public health concerns, notably through population-based studies examining tattoo associations with cutaneous squamous cell carcinoma. Engfeldt actively supervises doctoral candidates including Lejding, T. (chromate eczema prevention), Woo-Sampson, P. (oral irritant-skin sensitivity connections), and Young, E. (hairdye allergy mechanisms). She currently leads or assists five research projects, most prominently the SafeChrom initiative on chromium toxicity and the SAM-Krom biomonitoring study in Danish workplaces. As a core member of the SafeChrom Project Team, she collaborates internationally with Danish institutions and Lund University researchers to translate molecular findings into practical workplace safety protocols, with ongoing field studies in industrial chromium exposure settings.

Marianne FarneboView profile

Senior Lecturer

• Non-coding RNA
• RNA-binding proteins
• DNA repair
• +7 more

Marianne Farnebo is a Senior Lecturer (Docent) at the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Her research focuses on non-coding RNA and RNA-binding proteins in DNA repair, with implications for cancer and developmental disorders. She leads a research group that combines molecular techniques with clinical collaborations to explore RNA-guided DNA repair mechanisms. Doctorate in Oncology-Pathology (Karolinska Institutet, 2003) Master of Medical Science (Karolinska Institutet, 1999) Docent (Karolinska Institutet, 2011) Her research investigates how non-coding RNA and RNA-binding proteins regulate DNA repair pathways, particularly DNA double-strand breaks, and their role in cancer progression and treatment response. The group uses whole-genome sequencing, large-scale screens, and in vivo models (patient-derived cells, murine systems) to uncover RNA-driven mechanisms for genome stability. The most recent articles highlight WRAP53β’s involvement in Cajal body formation, DNA repair pathway choice, and radiotherapy prognosis across cancers (breast, ovarian, head/neck). Themes include RNA pseudouridylation, ubiquitination regulation, and RNA-histone interactions modulating chromatin structure. Grants and funding include support from the Swedish Cancer Society, Swedish Research Council, StratCan, Cancer Society of Stockholm, Karolinska Institute, Wenner-Gren Foundation, and BRECT (Breast Cancer Theme Center). Research team consists of Ph.D. students Linn Hjelmgren and Qianyu Zhou, alongside affiliated members like Sara Lazzari and Sandro Schmidli. Collaborations span oncologists, pathologists, and international researchers.

Olle SangfeltView profile

Researcher

• Cancer and Oncology
• Cell and Molecular Biology
• Medical Genetics and Genomics
• +6 more

Olle Sangfelt is a Principal Researcher and Docent at the Department of Cell and Molecular Biology , Karolinska Institutet. His research focuses on the role of SCF ubiquitin ligases, cell cycle regulation, and transcriptional control in cancer development and progression. He is particularly interested in mechanisms of drug resistance and tumor recurrence. Education: PhD (1998) in Oncology-Pathology, Karolinska Institutet; Docent (2011). Research areas: His work bridges molecular biology with translational cancer research, emphasizing ubiquitin signaling, replication stress response, and therapeutic vulnerability identification. Collaborations span institutions in Sweden, Italy, Finland, and the USA. Article trends: Recent publications highlight SCF ligase subunits (FBXL12, FBXO44) SOX9-positive latent cells in medulloblastoma recurrence Ubiquitin-dependent DNA repair mechanisms Combination therapies for leukemia and neuroblastoma Single-cell analysis of tumor heterogeneity